At the DZIF partner site in Giessen, a ceremonial kickoff meeting marked the launch of the GUARDIAN research project, which is funded with 3.5 million euros by the Federal Ministry of Research
Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this virus. This could change with the identification of
The Institute of Infectious Diseases and Tropical Medicine has announced the inclusion of the first study participant in the STEP2C Stage 3 trial. The study is part of the international UNITE4TB
The DZIF Transplant Cohort (Tx Cohort) provides interested researchers and study groups with extensive medical data on over 3,000 transplant recipients, focusing on infections. The cohort data is
Approximately one in 10,000 people in Germany is affected by primary sclerosing cholangitis (PSC). In order to digest fats from food, the intestine needs bile. This is produced in the liver and from
He is one of the world's leading clinical researchers in the field of tuberculosis (TB): Prof. Dr. Dr. h. c. Christoph Lange has been awarded the DZIF Prize for Translational Infection Research 2025
Prof. Achim Hörauf, Director of the Institute of Medical Microbiology, Immunology and Parasitology at the University Hospital Bonn and scientist at the German Center for Infection Research (DZIF), has
An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site and overcomes previous limitations of known antibodies. The study, led by
Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (DZIF), today announced a strategic research
INCATE (INCubator for Antibacterial Therapies in Europe), the antimicrobial incubator supporting the advancement of early stage anti-infectives, announced a defining milestone in its institutional
